Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
Last trade$186.66
Day change-$1.57 (-0.83%)
Day range$185.88 – $188.25
Volume100,892
Market cap$10.98B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$10.98B
Price / earnings
27.51×
Price / book
4.29×
Price / sales
1.94×
EV / sales
1.91×
EV / EBITDA
17.22×
Profitability
Earnings per share
$6.84
Return on assets
6.65%
Return on equity
15.59%
Dividend yield
0.14%
Liquidity and leverage
Debt / equity
0.08×
Current ratio
1.2×
Quick ratio
1.2×
Cash ratio
0.35×
Cash flow
Price / cash flow
15.79×
Price / free cash flow
21.54×
Free cash flow
$509.91M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ENSG, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.48B
$1.44B
$1.39B
$1.36B
$1.3B
$1.23B
$1.17B
$1.13B
Cost of revenue
$1.23B
$1.13B
$1.1B
$898.99M
$1.11B
$971.78M
$927.85M
$737.33M
Gross profit
$250.23M
$306.24M
$293.37M
$461.64M
$190.22M
$255.99M
$245.19M
$394.92M
Selling, general and administrative
$79.6M
$85.92M
$74.21M
$70.79M
$67.37M
$69.11M
$62.56M
$55.61M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$112.24M
$183.74M
$168.52M
$337.82M
$94M
$152.09M
$143.82M
$294.15M
Operating income
$137.99M
$122.5M
$124.85M
$123.81M
$96.22M
$103.9M
$101.37M
$100.78M
Interest expense
-$2.29M
-$1.93M
-$1.93M
-$1.96M
-$1.97M
-$2.03M
-$2.04M
-$2.26M
Income before taxes
$140.2M
$133.67M
$128.57M
$130.08M
$106.6M
$112.36M
$106.58M
$105.76M
Income taxes
$35.81M
$33.84M
$28.82M
$34.55M
$22.69M
$27.89M
$26.23M
$26.01M
Net income
$104.38M
$99.83M
$99.76M
$95.53M
$83.91M
$84.47M
$80.35M
$79.75M
Net income attributable to common shareholders
$104.26M
$99.74M
$99.67M
$95.45M
$83.84M
$84.4M
$80.28M
$79.69M
EBITDA
$170.64M
$153.91M
$153.65M
$151.53M
$122.85M
$129.69M
$125.56M
$123.3M
Basic earnings per share
$1.80
$1.72
$1.73
$1.66
$1.46
$1.48
$1.41
$1.40
Diluted earnings per share
$1.76
$1.68
$1.67
$1.61
$1.42
$1.44
$1.37
$1.36
Recent news
Company coverage with links to the original publishers.
Rosen Law Firm is reminding investors who purchased securities of The Ensign Group, Inc. between February 10, 2022 and June 18, 2026 about an important December 7, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Ensign made false statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare claims, falsification of nursing assistant hours, and illegal licensing schemes.
Kaplan Fox has filed a securities class action lawsuit against The Ensign Group on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The complaint alleges that Ensign's business model relies on systematic neglect of elderly patients, fraudulent Medicaid/Medicare claims, and falsification of records. Following a June 8, 2026 investigative report by Hunterbrook Media detailing these allegations, Ensign's stock fell 8.15% to $156.42 per share. The deadline to join the class action is December 7, 2026.
Kaplan Fox has filed securities class action lawsuits against Duolingo, The Ensign Group, and Coastal Financial Corporation, alleging false and misleading statements to investors. Duolingo faces allegations of concealing negative impacts of increased ad volume and AI-generated content on user growth, with significant stock price drops following disappointing financial results. The lead plaintiff deadline is December 7, 2026 for Duolingo and Ensign Group, and December 1, 2026 for Coastal Financial.
A class action securities lawsuit has been filed against The Ensign Group, Inc. for allegedly making materially false statements and failing to disclose systematic neglect of elderly residents in its facilities. The lawsuit covers investors who purchased Ensign securities between February 10, 2022 and June 18, 2026. Investors have until December 7, 2026 to request appointment as lead plaintiff.
The Ensign Group announced that 101 of its independently operating affiliates have been recognized as Best Nursing Homes for 2027 by U.S. News & World Report, earning the highest 'High Performing' rating. This recognition reflects only 18% of evaluated facilities nationwide and demonstrates the company's commitment to clinical excellence and resident-centered care.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 30, 2026
$0.065
Oct 31, 2026
recurring
Jun 30, 2026
$0.065
Jul 31, 2026
recurring
Mar 31, 2026
$0.065
Apr 30, 2026
recurring
Dec 31, 2025
$0.065
Jan 31, 2026
recurring
Sep 30, 2025
$0.0625
Oct 31, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.